News of Venetoclax

Venetoclax, also known as Venetoclax or Venetola, is a novel oral small molecule drug targeting BCL-2, developed in collaboration between AbbVie Inc in the United States and Genentech, a subsidiary of Roche Group inSwitzerland.Venetoclax exerts therapeutic effects by inhibiting the expression of BCL-2 protein, inducing cancer cells to enter an apoptotic state.

Venetoclax

Indications： It is mainly used for the treatment of chronic lymphocytic leukaemia (CLL), small lymphocytic lymphoma (SLL) and certain types of acute myeloid leukaemia (AML).

Scan code
Whatsapp

Medicine-related columns

Recommended Articles

How much do the different versions of venetoclax cost?

Venetoclax is a drug used to treat leukemias, specifically chronic lymphocytic leukemia and acute myeloid leukemia. It effectively kills cancer cells by interfering with their surv···【more】
Article source：Lucius LaosRelease date：2024-08-09Recommended：139
How many versions of venetoclax are there?

Venetoclax is a BCL-2 inhibitor that selectively binds to BCL-2 protein and inhibits anti-apoptotic function. This inhibition disrupts the interaction between BCL-2 and apoptosis r···【more】
Article source：Lucius LaosRelease date：2024-08-09Recommended：148
What is venetoclax?

Venetoclax is a drug used to treat chronic lymphocytic leukemia (CLL) and certain types of acute myeloid leukemia (AML). It induces apoptosis in cancer cells by inhibiting the BCL-···【more】
Article source：Lucius LaosRelease date：2024-08-09Recommended：143

home page previous 1 1/1 next last page

Lucius Pharmaceuticals

Lucius Pharmaceuticals (Lao) LTD. (Lucius Pharmaceuticals), with its manufacturing campus in Laos located in the capital city of Vientiane in 2020, officially begins its great journey to make effective and affordable medicines available to people in need around the world...More